The holiday season kicks into high gear with Thanksgiving weekend, and there are plenty of special events in New Orleans ...
Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis (MASH) for $4.7 billion upfront, shortly after claiming FDA approval to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback